These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14931128)

  • 1. [Malignant degeneration of benign tumors of the breast].
    VOGEL G
    Strahlentherapie; 1952; 87(1):150-1. PubMed ID: 14931128
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrasonic Nakagami imaging: a strategy to visualize the scatterer properties of benign and malignant breast tumors.
    Tsui PH; Yeh CK; Liao YY; Chang CC; Kuo WH; Chang KJ; Chen CN
    Ultrasound Med Biol; 2010 Feb; 36(2):209-17. PubMed ID: 20018436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytosterols and cholesterol in malignant and benign breast tumors.
    Mellies MJ; Ishikawa TT; Glueck CJ; Crissman JD
    Cancer Res; 1977 Sep; 37(9):3034-6. PubMed ID: 884660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI.
    Liu C; Liang C; Liu Z; Zhang S; Huang B
    Eur J Radiol; 2013 Dec; 82(12):e782-9. PubMed ID: 24034833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Degeneration of benign breast tumors including chronic cystic mastopathy].
    VOGEL G
    Krebsarzt; 1951 Aug; 6(7-8):230. PubMed ID: 14862136
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffusion weighted imaging for the differentiation of breast tumors: From apparent diffusion coefficient to high order diffusion tensor imaging.
    Teruel JR; Goa PE; Sjøbakk TE; Østlie A; Fjøsne HE; Bathen TF
    J Magn Reson Imaging; 2016 May; 43(5):1111-21. PubMed ID: 26494124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Distinguishing benign and malignant lesions with time-signal intensity curve of dynamic contrast-enhanced breast MRI scanning].
    Yuan HM; Yu JQ; Chu ZG; Peng LQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):556-9. PubMed ID: 21866648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of benign and malignant breast tumors using Doppler spectral parameters including acceleration time index.
    Mesaki K; Hisa N; Kubota K; Hisa N; Ogawa Y; Yoshida S
    Oncol Rep; 2003; 10(4):945-50. PubMed ID: 12792750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of miR-9 in benign and malignant breast tumors.
    Hasanzadeh A; Mesrian Tanha H; Ghaedi K; Madani M
    Mol Cell Probes; 2016 Oct; 30(5):279-284. PubMed ID: 27725294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving suspicious breast lesion characterization using semi-automatic lesion fractional volume washout kinetic analysis.
    Huang J; Hahn T; Hoisington L; Schafer S; Zong X; Berger K
    Med Phys; 2011 Nov; 38(11):5998-6009. PubMed ID: 22047364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
    Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
    Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nerves of human breast benign and malignant tumors].
    POL'KINA RI
    Vopr Onkol; 1955; 1(4):22-9. PubMed ID: 13299814
    [No Abstract]   [Full Text] [Related]  

  • 13. [Histological and endocrinological relationship between malignant and benign tumors of the breast].
    TOKUYAMA H; SAWADA A; MIZOTA S; TUKADA K
    Gan; 1955 Sep; 46(2-3):311-3. PubMed ID: 13262381
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential Diagnosis of Benign and Malignant Breast Tumors Using Apparent Diffusion Coefficient Value Measured Through Diffusion-Weighted Magnetic Resonance Imaging.
    Qu RF; Guo DR; Chang ZX; Meng J; Sun Y; Hao SH; Shi G; Sun J
    J Comput Assist Tomogr; 2015; 39(4):513-22. PubMed ID: 25783797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain-compounding technique with ultrasound Nakagami imaging for distinguishing between benign and malignant breast tumors.
    Liao YY; Li CH; Tsui PH; Chang CC; Kuo WH; Chang KJ; Yeh CK
    Med Phys; 2012 May; 39(5):2325-33. PubMed ID: 22559602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of RIP1K and RIP3K expressions in the malignant and benign breast tumors.
    Karami-Tehrani F; Malek AR; Shahsavari Z; Atri M
    Tumour Biol; 2016 Jul; 37(7):8849-56. PubMed ID: 26749282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic changes in benign and malignant breast tumors and the mechanism].
    Li YJ; Yang L; Xia Q; Wen G
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1557-60. PubMed ID: 19726291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of PDE5 and PDE9 expression in benign and malignant breast tumors.
    Karami-Tehrani F; Moeinifard M; Aghaei M; Atri M
    Arch Med Res; 2012 Aug; 43(6):470-5. PubMed ID: 22960860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
    Tahiri A; Leivonen SK; Lüders T; Steinfeld I; Ragle Aure M; Geisler J; Mäkelä R; Nord S; Riis ML; Yakhini Z; Kleivi Sahlberg K; Børresen-Dale AL; Perälä M; Bukholm IR; Kristensen VN
    Carcinogenesis; 2014 Jan; 35(1):76-85. PubMed ID: 24104550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.